Privia Health Group Inc (NAS:PRVA)

Q3 2025 Privia Health Group Inc Earnings Call Transcript

Nov 6, 2025 / 01:00 PM GMT

Release Date Price: $23.98 (-4.16%)

Transcript 10-Q8-K

Key Points

Positve

Privia Health Group Inc (PRVA) reported strong financial performance with a 61.6% increase in adjusted EBITDA and a 720 basis point expansion in EBITDA margin.
The company achieved a 27.1% growth in practice collections, supported by a 13.1% increase in implemented provider growth and a 12.8% growth in value-based attribution.
Privia Health Group Inc (PRVA) successfully managed over $2.5 billion in medical spend across its ACOs and MSSP, achieving a 9.4% aggregate savings rate.
The acquisition of Avalent Health's ACO business is expected to add over 120,000 value-based care attributed lives and contribute positively to adjusted EBITDA in 2026.
Privia Health Group Inc (PRVA) maintains a strong financial position with $409.9 million in pro forma cash and no debt, providing significant financial flexibility.

Negative

The financial results reported are preliminary and subject to change upon filing with the SEC.
The company faces uncertainties and risks that may cause actual results to differ materially from forward-looking statements.
Privia Health Group Inc (PRVA) does not provide quarterly guidance, which may lead to uncertainty in short-term performance expectations.
The integration of Avalent Health's ACO business may take time to realize full synergies and performance improvements.
The company remains cautious on capitated MA contracts due to ongoing pressures in the Medicare Advantage environment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRVA.OQ - Privia Health Group Inc
Q3 2025 Privia Health Group Inc Earnings Call
Nov 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the Previa Health 3rd quarter 2025 results conference call. Please note that this call is being recorded. You will have the opportunity to ask questions to our speakers later on during the community session. If you would like to ask a question by the time, please press 1 on your telephone keypad.

Thank you. I'd like to hand the call over to Robert Borchardt, as VP of Investor and Corporate Communication. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Chris, and good morning everyone. Joining me are Parth Merotra, our

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.